Apneic Oxygenation Including Precipitous Intubations During RSI in the ED (RAPID)
Randomized Controlled Trial of Apneic Oxygenation Including Precipitous Intubations During RSI in the Emergency Department
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Jersey
-
Newark, New Jersey, United States, 07103
- University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The inclusion criteria for our study will include patients 18 years or older who require emergent endotracheal intubation utilizing rapid sequence intubation (RSI) in the Emergency Department with first attempt taken by a resident or attending physician working in the emergency department. This includes Emergency Medicine attending physicians and residents as well as non-Emergency Medicine rotators (e.g.., Internal Medicine residents who are rotating through the Emergency Department).
Exclusion Criteria:
- Exclusion criteria include patients who are in cardiac arrest, or if the patient received any positive pressure ventilation (i.e, BPAP, CPAP, BVM) in the emergency department before RSI.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Apneic Oxygenation
Participants receiving apneic oxygenation
|
Providing oxygenation through nasal cannula during the apneic phase of endotracheal intubation.
|
|
No Intervention: No Apneic Oxygenation
Participants not receiving apneic oxygenation
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lowest oxygen saturation overall
Time Frame: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
Lowest oxygen saturation between overall control and intervention groups
|
Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lowest oxygen saturation precipitous intubations
Time Frame: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
Lowest oxygen saturation between control and intervention groups that did not receive adequate pre-oxygenation only
|
Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
|
Lowest oxygen saturation pre-oxygenation
Time Frame: Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
Lowest oxygen saturation between control and intervention groups that did receive
|
Time between neuromuscular blockade and 2 minutes after completion of endotracheal intubation
|
|
Difference in baseline and final oxygen saturation
Time Frame: Decision to intubate through 2 minutes after completion of endotracheal intubation
|
Decision to intubate through 2 minutes after completion of endotracheal intubation
|
|
|
Difference in oxygen saturation before and after apneic period
Time Frame: Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
|
Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
|
|
|
Desaturation
Time Frame: Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
|
The proportion of patients who desaturate below 90%
|
Initiation of neuromuscular blockade through 2 minutes after completion of endotracheal intubation
|
|
number of attempts
Time Frame: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
number of times laryngoscope is placed into the mouth in an attempt to pass an endotracheal tube
|
From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
|
Need for second operator
Time Frame: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
A second physician had to attempt intubation
|
From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
|
Need for additional intubating equipment
Time Frame: From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
The operator needed to change or add equipment to facilitate intubation
|
From first attempt at intubation through completion of endotracheal intubation procedure, approximately 2 minutes.
|
|
Esophageal intubations
Time Frame: From first attempt at intubation through entire ED stay, approximately 6 hours.
|
The proportion of intubations that resulted in the endotracheal tube being placed in the esophagus
|
From first attempt at intubation through entire ED stay, approximately 6 hours.
|
|
Procedural hypotension
Time Frame: Initiation of neuromuscular blockade to 2 minutes after completion of endotracheal intubation
|
Proportion of became hypotensive at any point during the intubation procedure
|
Initiation of neuromuscular blockade to 2 minutes after completion of endotracheal intubation
|
|
Aspiration
Time Frame: Within 24 hours after intubation procedure was complete
|
Proportion of patients that had evidence of aspiration
|
Within 24 hours after intubation procedure was complete
|
|
Hospital length of stay
Time Frame: Up to 28 days after intubation
|
Number of days patient is hospitalized
|
Up to 28 days after intubation
|
|
Number of days intubated
Time Frame: Up to 28 days after intubation
|
Up to 28 days after intubation
|
|
|
In-hospital mortality
Time Frame: Up to 28 days after intubation
|
Up to 28 days after intubation
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Ilya Ostrovsky, MD, Rutgers, The State University of New Jersey
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Pro2018000579
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.